Anjali Shukla
FDA investigator
Appears on 3 documents from 2017 to 2022, most often at sites in Austria. Most often cites written procedures; deviations (21 CFR 211.100).
- 3
- Documents on file
- 2.7
- Observations per 483
- 2017
- First seen
- 2022
- Most recent
What they cite most
From 8 observations- 21 CFR 211.100Written procedures; deviations3
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.25Personnel qualifications1
- 21 CFR 211.67Equipment cleaning and maintenance1
Activity by year
2017: 1, 2020: 1, 2022: 1
Where
Austria 1 · Malaysia 1 · Maryland 1
Often inspects with
Is Anjali Shukla coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
3 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-08-30 | 483 Form 483 · FEI 3011248248Aug 30, 2022 · Iskandar Puteri, Johor, Malaysia | Iskandar Puteri, Johor, Malaysia | 4 | |
| 2020-01-29 | 483 Human Genome Sciences, Inc.Jan 29, 2020 · Rockville, Maryland | Rockville, Maryland | 3 | |
| 2017-10-13 | 483 Sandoz GmbHOct 13, 2017 · Langkampfen, Austria | Langkampfen, Austria | 1 |
About this profile
What does Anjali Shukla inspect?
Anjali Shukla appears on 3 documents on file covering 3 sites, most often in Austria.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.113 and 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Anjali Shukla is dated Aug 30, 2022.